Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
amylas 30 000 enheter + lipas 8 000 enheter + proteas 30 000 enheter, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
amylas 6 000 enheter + lipas 16 000 enheter + proteas 6 000 enheter, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
amylas 8 000 enheter + lipas 30 000 enheter + proteas 30 000 enheter, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
amylas 12 500 enheter + pankreaslipas 1 000 enheter + pankreasproteas 12 500 enheter, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Aspirin 325 mg and carisoprodol 200 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Aspirin 500 mg and hydrocodone bitartrate 5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Aspirin 325 mg and meprobamate 200 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Aspirin 325 mg and methocarbamol 400 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
acetylsalicylsyra + pentazocinhydroklorid 325 mg, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Atenolol 100 mg and chlortalidone 25 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Atenolol 50 mg and chlortalidone 25 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
atovakvon 62,5 mg + proguanilhydroklorid 25 mg, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
atropin 25 mikrogram och difenoxinhydroklorid 1 milligram, oral tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
bisoprolol 5 milligram och hydroklortiazid 6,25 milligram, oral tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Captopril 25 mg and hydrochlorothiazide 15 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Captopril 25 mg and hydrochlorothiazide 25 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Captopril 50 mg and hydrochlorothiazide 15 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
karbidopa 50 mg + levodopa 200 mg, tablett med modifierad frisättning |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
karbidopa 10 mg + levodopa 100 mg, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
karbidopa 25 mg + levodopa 100 mg, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
karbidopa 25 mg + levodopa 250 mg, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Chlorothiazide 250 mg and methyldopa 250 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Chlorothiazide 250 mg and reserpine 125 microgram oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
klorfeniraminmaleat + metskopolaminnitrat + pseudoefedrinhydroklorid 8 mg/2,5 mg/120 mg, tablett med modifierad frisätttning |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 300 microgram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Choline bitartrate 25 mg and dexpanthenol 50 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Deserpidine 250 microgram and methyclothiazide 5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely deserpidine 500 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
/// desogestrel 0,15 mg + etinylestradiol 0,01 mg + etinylestradiol 0,01 mg, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
desogestrel 0,15 mg + etinylestradiol 0,03 mg, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Diltiazem maleate 219 mg and enalapril maleate 5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Diprophylline 100 mg and guaifenesin 100 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
enalapril 10 milligram och hydroklortiazid 25 milligram, oral tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
enalapril 5 milligram och hydroklortiazid 12,5 milligram, oral tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
estradiol 1 mg + estradiol 1 mg + norgestimat 0,09 mg, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Estradiol + norethindrone acetate 1mg/0.5mg tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely esterified estrogen 625 microgram and methyltestosterone 1.25 milligram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely esterified estrogen 1.25 milligram and methyltestosterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Ethinylestradiol 35 microgram and etynodiol diacetate 1 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Ethinylestradiol 50 microgram and etynodiol diacetate 1 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Ethinylestradiol 30 microgram and ferrous fumarate 75 mg and norgestrel 300 microgram oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Ethinylestradiol 20 microgram and levonorgestrel 100 microgram oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Ethinyl estradiol + levonorgestrel 0.03mg/0.15mg tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely ethinylestradiol 40 microgram and levonorgestrel 75 microgram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
etinylestradiol 0,05 mg + levonorgestrel 0,25 mg, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
etinylestradiol 0,035 mg + noretindron 0,5 mg, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Ethinylestradiol 35 microgram and norethisterone 1 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Ethinylestradiol 50 microgram and norethisterone 1 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
etinylestradiol 20 mikrogram + noretindronacetat 1 mg, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
etinylestradiol 30 mikrogram + noretindronacetat 1,5 mg, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Ethinyl estradiol + norgestimate 0.035mg/0.25mg tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Ethinylestradiol 30 microgram and norgestrel 300 microgram oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely ethinylestradiol 50 microgram and norgestrel 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Ferrous fumarate 324 mg and folic acid 1 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydrochlorothiazide 25 mg and methyldopa 250 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydrochlorothiazide 30 mg and methyldopa 500 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydrochlorothiazide 25 mg and propranolol hydrochloride 40 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydrochlorothiazide + quinapril hydrochloride 12.5mg/10mg tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely hydrochlorothiazide 25 milligram and quinapril 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydrochlorothiazide 50 mg and reserpine 125 microgram oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydrochlorothiazide 12.5mg/telmisartan 40mg tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Hydrocodone bitartrate 7.5 mg and ibuprofen 200 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Isoniazid + pyrazinamide + rifampin 50mg/300mg/120mg tablet |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
levotyroxin 38 mikrogram + liotyronin 9 mikrogram, tablett |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
Inferred relationship |
Some |
|